Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹564.70
Market cap: ₹1,131 Cr
Revenue (annual): ₹671.0 Cr
Net profit (annual): ₹87.89 Cr
P/E (TTM): 11.7×Sector 47.4×
Promoter holding: 49.78%+0.00% QoQ
FII holding: 4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 3 Board Meeting Date 2 Results Correction 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Apr 2026 18:25 IST NSE

Results Correction

Lincoln Pharmaceuticals Results Correction

Lincoln Pharmaceuticals Limited clarified to the NSE that its standalone and consolidated financial figures for Q2 FY2026 are identical because its sole subsidiary had no financial transactions during that period. This response addresses the exchange's query regarding financial result formatting and confirms the accuracy of the previously reported results.

Read the filing ↗